Drug profile · INN
diclofenac potassium
DICLOFENAC POTASSIUM
diclofenac potassium (DICLOFENAC POTASSIUM) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — diclofenac potassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.89
Quick answer
diclofenac potassium (DICLOFENAC POTASSIUM) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Cyclooxygenase inhibitor
Primary target: Cyclooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is diclofenac potassium?
diclofenac potassium (DICLOFENAC POTASSIUM) is a cyclooxygenase inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for diclofenac potassium?
DICLOFENAC POTASSIUM is a marketed brand name for diclofenac potassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of diclofenac potassium?
diclofenac potassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.